Daniel Duerschmied Selected Research

human APOA1 protein

1/2019

The CSL112-2001 trial: Safety and tolerability of multiple doses of CSL112 (apolipoprotein A-I [human]), an intravenous formulation of plasma-derived apolipoprotein A-I, among subjects with moderate renal impairment after acute myocardial infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel Duerschmied Research Topics

Disease

29	COVID-19 08/2022 - 01/2020
18	Inflammation (Inflammations) 01/2022 - 11/2011
14	Thrombosis (Thrombus) 01/2022 - 09/2010
10	Hemorrhage 07/2022 - 08/2008
10	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 11/2021 - 01/2020
10	Myocardial Infarction 01/2021 - 01/2015
8	Coronary Artery Disease (Coronary Atherosclerosis) 07/2022 - 01/2012
8	Pulmonary Embolism 01/2022 - 01/2016
6	Stroke (Strokes) 07/2022 - 01/2015
6	Reperfusion Injury 01/2022 - 08/2014
6	Heart Arrest (Cardiac Arrest) 01/2022 - 01/2018
5	Neoplasms (Cancer) 06/2022 - 06/2003
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2018
5	Pneumonia (Pneumonitis) 04/2021 - 01/2020
5	Shock 01/2021 - 02/2013
5	Acute Coronary Syndrome 12/2019 - 09/2010
4	Myocarditis (Carditis) 01/2022 - 08/2019
4	Atherosclerosis 01/2022 - 11/2011
4	Thrombocytopenia (Thrombopenia) 01/2022 - 08/2008
4	Critical Illness (Critically Ill) 01/2022 - 01/2019
3	ST Elevation Myocardial Infarction 01/2021 - 07/2018
3	Myocardial Ischemia (Ischemic Heart Diseases) 12/2019 - 08/2014
2	Infections 08/2022 - 04/2021
2	Breast Neoplasms (Breast Cancer) 06/2022 - 01/2022
2	Infarction (Infarctions) 01/2022 - 12/2019
2	Cardiogenic Shock 09/2021 - 09/2019
2	Human Influenza (Influenza) 06/2021 - 01/2021
2	Respiratory Insufficiency (Respiratory Failure) 04/2021 - 01/2021
2	Body Weight (Weight, Body) 04/2021 - 06/2020
2	Atrial Fibrillation 01/2020 - 12/2019
2	Wounds and Injuries (Trauma) 01/2020 - 02/2013
1	Emergence Delirium 07/2022
1	Pathologic Constriction (Stenosis) 07/2022
1	Cardiotoxicity 06/2022
1	Septic Shock (Toxic Shock Syndrome) 01/2022
1	Post-Cardiac Arrest Syndrome 01/2022
1	Fever (Fevers) 01/2022

Drug/Important Bio-Agent (IBA)

10	CytokinesIBA 01/2022 - 01/2016
10	Serotonin (5 Hydroxytryptamine)IBA 01/2022 - 08/2008
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
5	AnticoagulantsIBA 03/2022 - 09/2010
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2003
5	RivaroxabanIBA 01/2021 - 01/2016
4	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2020
3	AntibodiesIBA 01/2022 - 01/2021
3	VaccinesIBA 01/2022 - 10/2021
3	Heparin (Liquaemin)FDA LinkGeneric 09/2021 - 09/2010
3	Dabigatran FDA Link 09/2021 - 12/2017
3	Factor Xa InhibitorsIBA 01/2021 - 01/2016
2	Complement System Proteins (Complement)IBA 05/2022 - 10/2018
2	TroponinIBA 01/2022 - 03/2017
2	LigandsIBA 01/2022 - 01/2018
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2019
2	LipopolysaccharidesIBA 01/2022 - 02/2013
2	Prasugrel Hydrochloride FDA Link 01/2022 - 12/2021
2	Freund's AdjuvantIBA 12/2021 - 01/2020
2	Cardiac MyosinsIBA 12/2021 - 01/2020
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2021 - 10/2019
2	N(4)-oleylcytosine arabinosideIBA 01/2020 - 12/2019
2	Vitamin K FDA Link 12/2019 - 12/2017
2	Peptides (Polypeptides)IBA 12/2019 - 11/2011
2	CD40 Ligand (CD40L)IBA 10/2019 - 11/2011
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2018 - 01/2012
2	Glycoproteins (Glycoprotein)IBA 10/2018 - 08/2008
2	MicroRNAs (MicroRNA)IBA 07/2018 - 01/2018
2	IntegrinsIBA 01/2018 - 08/2008
2	ferric chlorideIBA 05/2014 - 10/2011
2	Tryptophan HydroxylaseIBA 03/2013 - 02/2013
2	Clopidogrel (Plavix)FDA Link 01/2012 - 09/2010
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2022
1	2-bromolysergic acid diethylamide (BOL)IBA 08/2022
1	Enoxaparin (Lovenox)FDA LinkGeneric 08/2022
1	AntigensIBA 05/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	fibrin fragment D (D-dimer)IBA 01/2022
1	CC ChemokinesIBA 01/2022
1	Fibrinogen (Factor I)FDA Link 01/2022
1	Interferon Type IIBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	LDL Receptors (LDL Receptor)IBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	Purinergic Receptors (Receptors, Purine)IBA 01/2022
1	NucleotidesIBA 01/2022
1	Cell-Free Nucleic AcidsIBA 01/2022
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2022
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022

Therapy/Procedure

20	Therapeutics 06/2022 - 09/2010
20	Extracorporeal Membrane Oxygenation 11/2021 - 01/2019
6	Cardiopulmonary Resuscitation (CPR) 01/2022 - 05/2019
5	Percutaneous Coronary Intervention 01/2020 - 09/2010
4	Artificial Respiration (Mechanical Ventilation) 08/2022 - 06/2020
4	Stents 07/2022 - 09/2010
3	Resuscitation 12/2021 - 06/2019
2	Length of Stay 05/2022 - 03/2022
2	Subcutaneous Injections 12/2021 - 01/2020
2	Critical Care (Surgical Intensive Care) 02/2021 - 01/2021
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 07/2022
1	Plasma Exchange 01/2022
1	Carotid Endarterectomy 01/2022